Brainstorm Cell Therapeutics Income Tax

Brainstorm Cell Therapeutics (BCLI) currently reports a income tax of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Brainstorm Cell Therapeutics's income tax history and peer comparisons.

Brainstorm Cell Therapeutics's income tax changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Brainstorm Cell Therapeutics reported $0 in income tax as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current income tax of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Brainstorm Cell Therapeutics, and consider following BCLI for alerts when major investors trade the stock.

Brainstorm Cell Therapeutics is classified in the Healthcare sector. On income tax, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BCLI with unrelated industries.